title: Psychotic disorder in a case with Hallervorden-Spatz disease.
abstract: OBJECTIVE
  Hallervorden-Spatz disease is a rare autosomal recessive condition, with early onset of predominantly extrapyramidal dysfunction. The symptoms of the disease are dystonia, rigidity, choreoathetosis, pyramidal signs, and intellectual decline. Recent genetic studies mapped the disease to chromosome 20p12.3-p13, and identified mutations in the pantothenate kinase gene. This report describes a childhood onset case of Hallervorden-Spatz disease with schizophreniform psychotic symptoms. Former reports about the psychiatric comorbidity generally included depressive disorder.
  
  
  METHODS
  A single case report.
  
  
  RESULTS
  A 14-year-old boy with Hallervorden-Spatz disease presented a psychotic episode with prominent auditory hallucinations. Symptoms were relieved after neuroleptic treatment.
  
  
  CONCLUSIONS
  To the authors' knowledge, this is the first published report of the disease with psychotic symptoms. The contribution of basal ganglia, with their wide projections, to the emergence of psychotic symptoms was discussed.
authors.affiliation: Ankara University Faculty of Medicine, Child Psychiatry Department, Cebeci, Ankara, Turkey. ozzoner@hotmail.com
authors.forename: O
authors.initials: O
authors.lastname: Oner
authors.forename: P
authors.initials: P
authors.lastname: Oner
authors.forename: G
authors.initials: G
authors.lastname: Deda
authors.forename: D
authors.initials: D
authors.lastname: Içağasioğlu
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D015897:Comorbidity; D003704:Dementia / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000523:psychology; D004292:Dominance, Cerebral / Q000502:physiology; D005917:Globus Pallidus / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009460:Neurologic Examination; D000077152:Olanzapine; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000523:psychology; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000523:psychology
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine